Harbor MedTech

About:

Harbor MedTech develops and commercializes tissue regeneration products for chronic wounds, hernia and joint repair, and more.

Website: http://harbormedtech.com

Top Investors: Alumni Ventures, MedTech Innovator, Bascom Ventures, Arsenal Capital Management, Total Access Fund

Description:

Harbor MedTech develops and commercializes tissue regeneration products for chronic wounds, hernia and joint repair, and more. It offers NeuvoCell, a wound therapy for chronic wounds, such as diabetic, venous, and pressure ulcers; products for hernia and joint repair, orthopedic soft tissue repair, breast reconstruction, and urogynecological repair; and Architect, a collagen matrix for treatment of partial and full-thickness skin wounds. Harbor MedTech, Inc. has a strategic partnership with Edwards Lifesciences. The company was founded in 2010 by Jim Jungwirth and Keith Myers and is based in Irvine, California.

Total Funding Amount:

$15.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Irvine, California, United States

Founded Date:

2010-01-01

Contact Email:

Support(AT)harbormedtech.com

Founders:

Jim Klingler, Keith Myers

Number of Employees:

11-50

Last Funding Date:

2017-09-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai